Chimeric Antigen Receptor 4Scar-Gd2-modified T Cells Targeting High-Risk and Recurrent Neuroblastoma: A Phase II Multi-Center Trial in ChinaLihua Yang,Xiaoli Ma,Yu-Chen Liu,Wen Zhao,Lihua Yu,Maoquan Qin,Guanghua Zhu,Kai Wang,Xiaodong Shi,Zhaoxia Zhang,Jingfu Wang,Yuan Sun,Lujia Dong,Shih-Ting Tsao,Rui Zhang,Lung-Ji ChangBlood（2017）引用 9|浏览71AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
